These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23568489)

  • 41. Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.
    Nieborowska-Skorska M; Sullivan K; Dasgupta Y; Podszywalow-Bartnicka P; Hoser G; Maifrede S; Martinez E; Di Marcantonio D; Bolton-Gillespie E; Cramer-Morales K; Lee J; Li M; Slupianek A; Gritsyuk D; Cerny-Reiterer S; Seferynska I; Stoklosa T; Bullinger L; Zhao H; Gorbunova V; Piwocka K; Valent P; Civin CI; Muschen M; Dick JE; Wang JC; Bhatia S; Bhatia R; Eppert K; Minden MD; Sykes SM; Skorski T
    J Clin Invest; 2017 Jun; 127(6):2392-2406. PubMed ID: 28481221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
    Prasad CB; Prasad SB; Yadav SS; Pandey LK; Singh S; Pradhan S; Narayan G
    Sci Rep; 2017 Oct; 7(1):12876. PubMed ID: 28993682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parp1-Dependent DNA Double-Strand Break Repair in Irradiated Late Pachytene Spermatocytes.
    Ahmed EA; Alzahrani AM; Scherthan H
    DNA Cell Biol; 2021 Feb; 40(2):209-218. PubMed ID: 33337266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yeast pol4 promotes tel1-regulated chromosomal translocations.
    Ruiz JF; Pardo B; Sastre-Moreno G; Aguilera A; Blanco L
    PLoS Genet; 2013; 9(7):e1003656. PubMed ID: 23874240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
    Byers LA; Wang J; Nilsson MB; Fujimoto J; Saintigny P; Yordy J; Giri U; Peyton M; Fan YH; Diao L; Masrorpour F; Shen L; Liu W; Duchemann B; Tumula P; Bhardwaj V; Welsh J; Weber S; Glisson BS; Kalhor N; Wistuba II; Girard L; Lippman SM; Mills GB; Coombes KR; Weinstein JN; Minna JD; Heymach JV
    Cancer Discov; 2012 Sep; 2(9):798-811. PubMed ID: 22961666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.
    Luijsterburg MS; de Krijger I; Wiegant WW; Shah RG; Smeenk G; de Groot AJL; Pines A; Vertegaal ACO; Jacobs JJL; Shah GM; van Attikum H
    Mol Cell; 2016 Feb; 61(4):547-562. PubMed ID: 26895424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of poly (ADP-ribose) polymerase 1 leads to change of hydroquinone cytotoxicity in TK6 cells.
    Sha Y; Zhou W; Yang Z; Zhu X; Yang X; Li TD; Zhu D
    Toxicol Mech Methods; 2015; 25(6):467-77. PubMed ID: 26335980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
    Hopkins TA; Shi Y; Rodriguez LE; Solomon LR; Donawho CK; DiGiammarino EL; Panchal SC; Wilsbacher JL; Gao W; Olson AM; Stolarik DF; Osterling DJ; Johnson EF; Maag D
    Mol Cancer Res; 2015 Nov; 13(11):1465-77. PubMed ID: 26217019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.
    Piao J; Takai S; Kamiya T; Inukai T; Sugita K; Ohyashiki K; Delia D; Masutani M; Mizutani S; Takagi M
    Cancer Lett; 2017 Feb; 386():131-140. PubMed ID: 27894958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications.
    Park SH; Jang KY; Kim MJ; Yoon S; Jo Y; Kwon SM; Kim KM; Kwon KS; Kim CY; Woo HG
    Oncotarget; 2015 Dec; 6(42):44819-31. PubMed ID: 26540566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
    Brenner JC; Ateeq B; Li Y; Yocum AK; Cao Q; Asangani IA; Patel S; Wang X; Liang H; Yu J; Palanisamy N; Siddiqui J; Yan W; Cao X; Mehra R; Sabolch A; Basrur V; Lonigro RJ; Yang J; Tomlins SA; Maher CA; Elenitoba-Johnson KS; Hussain M; Navone NM; Pienta KJ; Varambally S; Feng FY; Chinnaiyan AM
    Cancer Cell; 2011 May; 19(5):664-78. PubMed ID: 21575865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IER5 is involved in DNA Double-Strand Breaks Repair in Association with PAPR1 in Hela Cells.
    Yu XP; Wu YM; Liu Y; Tian M; Wang JD; Ding KK; Ma T; Zhou PK
    Int J Med Sci; 2017; 14(12):1292-1300. PubMed ID: 29104487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PARP-1 inhibition induces a late increase in the level of reactive oxygen species in cells after ionizing radiation.
    Cieślar-Pobuda A; Saenko Y; Rzeszowska-Wolny J
    Mutat Res; 2012 Apr; 732(1-2):9-15. PubMed ID: 22321899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
    Murmann-Konda T; Soni A; Stuschke M; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient-Derived Xenograft Models.
    Johnston ME; Rivas MP; Nicolle D; Gorse A; Gulati R; Kumbaji M; Weirauch MT; Bondoc A; Cairo S; Geller J; Tiao G; Timchenko N
    Hepatology; 2021 Oct; 74(4):2201-2215. PubMed ID: 34037269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poly(ADP-ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis.
    Meyer-Ficca ML; Lonchar JD; Ihara M; Meistrich ML; Austin CA; Meyer RG
    Biol Reprod; 2011 May; 84(5):900-9. PubMed ID: 21228215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.
    van Vuurden DG; Hulleman E; Meijer OL; Wedekind LE; Kool M; Witt H; Vandertop PW; Würdinger T; Noske DP; Kaspers GJ; Cloos J
    Oncotarget; 2011 Dec; 2(12):984-96. PubMed ID: 22184287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70.
    Boboila C; Jankovic M; Yan CT; Wang JH; Wesemann DR; Zhang T; Fazeli A; Feldman L; Nussenzweig A; Nussenzweig M; Alt FW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3034-9. PubMed ID: 20133803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of poly(ADP-ribose) polymerase 1 on integration of the adeno-associated viral vector genome.
    Romanova LG; Zacharias J; Cannon ML; Philpott NJ
    J Gene Med; 2011 Jun; 13(6):342-52. PubMed ID: 21674737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
    Schreiber V; Illuzzi G; Héberlé E; Dantzer F
    Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.